Do clades matter for HIV vaccines?

By Patricia Kahn, Ph.D.

As thousands of people prepare to gather in Nairobi and New York for September’s AIDS meetings, a key question for vaccine developers is how to contend with the huge diversity of HIV strains circulating worldwide